Resmed – Buy

ResMed is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.

RMD report earnings on the 24th Oct and the market is looking for 10%+ in EPS growth. We expect buying support to increase ahead of the result and see support building at $19.50.

You’re not a member!  Trial today

 

 

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.